Thus, this evidence suggests that loss-of-function mutations in KChIP2 could confer an increased susceptibility to both seizures and cardiac arrhythmias, increasing the risk to sudden unexpected death in epileptic patients. Here, KCNIP2 is linked to cardiac arrhythmia.